Major Shareholder Announcement
COPENHAGEN, Denmark; August 2, 2022 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Wellington Management Group LLP has informed us that, as of August 1, 2022, Wellington Management Group LLP through shares and financial instruments holds the voting rights to 3,277,839 shares in Genmab A/S, which amounts to 4.98% of the share capital and voting rights in Genmab A/S.
Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com and follow us on Twitter.com/Genmab.
Andrew Carlsen, Vice President, Head of Investor Relations
Company Announcement no. 38